Does Dr. SARAH AL BAYATI have financial conflicts of interest?

Dr. SARAH AL BAYATI (FNP) has received a total of $344 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $344 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SARAH AL BAYATI?

According to CMS Open Payments data, Dr. SARAH AL BAYATI received funding from MUSCULOSKELETAL TRANSPLANT FOUNDATION ($138), ASTRAZENECA PHARMACEUTICALS ($115), and KCI USA ($91).

Does Dr. SARAH AL BAYATI receive research grants or speaking fees?

Dr. SARAH AL BAYATI has received $344 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SARAH AL BAYATI

FNPReal-Time Hydrated

Specialty: Nurse Practitioner

Practice Location: LEXINGTON, KY 40504

NPI Number: 1710409222

LIFETIME INDUSTRY VALUE

$344

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AL BAYATI is a verified Nurse Practitioner practitioner based in LEXINGTON, KY.

Between 2021 and 2025, Dr. AL BAYATI had an overall industry promotional and research financial footprint of $344 as recorded in the federal CMS Open Payments database.

$344 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL BAYATI's primary funding source is MUSCULOSKELETAL TRANSPLANT FOUNDATION, which accounts for $138 (representing 40.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MUSCULOSKELETAL TRANSPLANT FOUNDATION

Rank 1

$138

40.3%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$115

33.3%

KCI USA

Rank 3

$91

26.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.